arrow
返回
K

K. Jalkanen

helsinki university hospital comprehensive cancer center

9H指数
44论文数
178被引数
收录论文 15
发表时间
A comprehensive assessment of the existing landscape of personalized cancer medicine in the European Union, on behalf of the PCM4EU consortium代表PCM4EU联盟,对欧洲联盟个性化癌症医学的现有格局进行全面评估。
err2025-11-06
err0
errOAAI
errS.F. Haj Mohammad; H. van der Pol; E. Vrdoljak; U. Lassen; K. Ojamaa; K. Jalkanen; L. Verlingue; A. Stenzinger; A. Patócs; G. Curigliano; E. Baltruškevičienė; Å. Helland; H.G. Russnes; I. Ługowska; B. Mainoli; A. Edsjö; E. Lonardi; K. Taskén; H. Gelderblom
err分享
err收藏
Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumors单次静脉注射溶瘤腺病毒TILT-123可导致晚期实体瘤患者的全身肿瘤转导和免疫反应
err2024-11-06
err0
errOAAI
errJirovec, Elise; Quixabeira, Dafne C. A.; Clubb, James H. A.; Pakola, Santeri A.; Kudling, Tatiana; Arias, Victor; Haybout, Lyna; Jalkanen, Katriina; Alanko, Tuomo; Monberg, Tine; Khammari, Amir; Dreno, Brigitte; Svane, Inge Marie; Block, Matthew S.; Adamo, Daniel A.; Maenpaa, Johanna; Kistler, Claudia; Sorsa, Suvi; Hemminki, Otto; Kanerva, Anna; Santos, Joao M.; Cervera-Carrascon, Victor; Hemminki, Akseli
err分享
err收藏
PRIME-ROSE: Merging clinical outcome data from DRUP-like clinical trialsPRIME-ROSE:合并来自DRUP类临床研究的临床结局数据
err2024-09-01
err0
PREAI
errKringelbach, T. M.; Fagereng, L.; Mohammad, S. F. Haj; Verbeek, F.; Timmer, H. J. L.; Juslin, T.; Verlingue, L.; Krebs, M. G.; Blay, J-Y.; Jalkanen, K.; Rohrberg, K. S.; Lassen, U. N.; Helland, A.; Verheul, H. M. W.; Voest, E. E.; Gelderblom, H.; Tasken, K.
err分享
err收藏
Addressing uncertainties of clinical value and improving access for newly authorised indications through DRUG-Access Protocol (DAP)-like platforms: Joint collection and evaluation of real-world evidence通过类似DRUG-Access Protocol (DAP)的平台解决临床价值的不确定性并改善新授权适应症的准入:真实世界证据的联合收集与评估
err2024-09-01
err0
PREAI
errvan Doorn-Khosrovani, S. B. van Waalwijk; Huisman, A. H.; Timmer, H. J. L.; Verkerk, K.; Verbeek, F.; Fagereng, L.; Helland, A.; Ryll, B.; Tasken, K.; Jalkanen, K.; Oliveira, J.; Lassen, U. N.; Blay, J-Y.; Gelderblom, H.; Reyners, A.; Eskens, F. A.; Smit, E. F.; Voest, E. E.; Bloemendal, H.
err分享
err收藏
Final analysis of the phase III LITESPARK-005 study of belzutifan versus everolimus in participants (pts) with previously treated advanced clear cell renal cell carcinoma (ccRCC)III期LITESPARK-005研究最终分析:比较belzutifan与everolimus在先前接受过治疗的晚期透明细胞肾细胞癌(ccRCC)患者(pts)中的效果
err2024-09-01
err2
PREAI
errRini, B. I.; Rodriguez, C. Suarez; Albiges, L.; Jalkanen, K.; Oria, G. A. De Velasco; Burotto, M.; Ghatalia, P.; Iacovelli, R.; Lam, E. T.; Verzoni, E.; Gumus, M.; Stadler, W.; Kollmannsberger, C. K.; Melichar, B.; Venugopal, B.; Lin, J.; Perini, R.; Vickery, D.; Choueiri, T. K.; Powles, T. B.
err分享
err收藏
FINPROVE: The Finnish national study to facilitate patient access to targeted anti-cancer drugsFINPROVE:芬兰国家研究,旨在促进患者获取靶向抗肿瘤药物
err2024-09-01
err0
PREAI
errMustonen, M. V. J.; Alanne, E.; Iivanainen, S. M. E.; Kaariainen, O-S.; Tanner, M. M. E.; Mattson, J.; Jalkanen, K.
err分享
err收藏
Fully intravenous delivery regimen of oncolytic adenovirus coding for TNFa and IL-2 (TILT-123) in patients with advanced solid cancers编码TNFa和IL-2的溶瘤腺病毒(TILT-123)在晚期实体瘤患者中的完全静脉给药方案
err2024-09-01
err0
PREAI
errPakola, S. A.; Jalkanen, K.; Alanko, T. V.; Clubb, J. H. A.; Quixabeira, D. C. A.; Jirovec, E.; Kudling, T.; Arias, V.; Korpisaari, R.; Jaakkola, M.; Kononen, T.; Sormunen, J.; Pellinen, T.; Haybout, L.; Kistler, C.; Sorsa, S.; Havunen, R.; Santos, J. M.; Cervera-Carrascon, V.; Hemminki, A.
err分享
err收藏
Clinical and molecular characteristics of gynecologic cancer patients in FINPROVE: The national phase II drug repurposing trial in FinlandFINPROVE试验中妇科癌患者的临床与分子特征:芬兰国家性二期药物重定位试验
err2024-09-01
err0
PREAI
errFarkkila, A.; Suoknuuti, A.; Lassus, H. J.; Tanner, M. M. E.; Alanne, E.; Kaariainen, O-S.; Iivanainen, S. M. E.; Auranen, A.; Simojoki, M. K.; Arola, J.; Pasanen, A.; Niemela, E.; Vainionpaa, R.; Kaikkonen, E.; Virtanen, A.; Kytola, S.; Jalkanen, K.
err分享
err收藏
Effectiveness of the Coordinated Return to Work model after orthopaedic surgery for lumbar discectomy and hip and knee arthroplasty: a register-based study
err2024-02-08
err4
errOAAI
errLavikainen, Piia; Heiskanen, Jari; Jalkanen, Kari; Lehtimaki, Aku-Ville; Vehkala, Saara; Kangas, Pauliina; Husman, Kaj; Vohlonen, Ilkka; Martikainen, Janne
err分享
err收藏
LDL-cholesterol trajectories and statin treatment in Finnish type 2 diabetes patients: a growth mixture model
err2021-11-19
err3
errOAAI
errInglin, Laura; Lavikainen, Piia; Jalkanen, Kari; Laatikainen, Tiina
err分享
err收藏
Type 2 Diabetes-Related Health Economic Impact Associated with Increased Whole Grains Consumption among Adults in Finland
err2021-10-13
err12
errOAAI
errMartikainen, Janne; Jalkanen, Kari; Heiskanen, Jari; Lavikainen, Piia; Peltonen, Markku; Laatikainen, Tiina; Lindstrom, Jaana
err分享
err收藏
Loss of Cln5 leads to altered Gad1 expression and deficits in interneuron development in mice
err2019-07-17
err12
errOAAI
errSingh, Yajuvinder; Leinonen, Henri; Fazaludeen, Feroze; Jaronen, Merja; Guest, Debbie; Buckley, Noel; Byts, Nadiya; Oksa, Petra; Jalkanen, Kari; Iqbal, Imran; Huuskonen, Mikko; Savchenko, Ekaterina; Keksa-Goldsteine, Velta; Chew, Sweelin; Myllyharju, Johanna; Tanila, Heikki; Ooi, Lezanne; Koistinaho, Jari; Kanninen, Katja M.; Malm, Tarja
err分享
err收藏
err分享
err收藏
THE EFFECTS OF TYPE 2 DIABETES ON HEALTH-RELATED QUALITY OF LIFE IN THE FINNISH POPULATION AS MEASURED WITH EQ-5D-5L
err2018-10-01
err0
errOAAI
errJalkanen, K.; Aarnio, E. J.; Lavikainen, P. T.; Jauhonen, H. M.; Enlund, H.; Martikainen, J. A.
err分享
err收藏